Victor Dasgupta | Nov 28, 2022, 6:50 PM IST
Bharat Biotech International Limited (BBIL) announced that iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO)
India.com News Desk | Sep 20, 2022, 12:42 AM IST
Arctic wolves are on the verge of extinction. To save them, China has created a new wolf by cloning Arctic wolves for the first time.
India.com News Desk | Aug 31, 2022, 3:54 PM IST
Giving details, Dr NK Arora, Chairperson of the COVID working group, National Technical Advisory Group on Immunisation (NTAGI) said it is an exciting experience to launch a made-in-India vaccine.
India.com Education Desk | Jun 4, 2022, 4:36 PM IST
GAT B, BET 2022 Scorecards: Candidates who have appeared for the GAT B and BET 2022 can now download their scorecards through the official website of dbt.nta.ac.in.
India.com News Desk | Apr 14, 2022, 6:09 PM IST
The Graduate Aptitude Test-Biotechnology (GAT-B)/Biotechnology Eligibility Test (BET) 2022 will be held in the computer-based mode (CBT) on April 23. The GAT-B exam will be held from 9 am to 12 pm, while the BET exam 2022 will be conducted from 3 pm to 6 pm.
India.com Education Desk | Feb 16, 2022, 4:55 PM IST
IIT JAM 2022 Latest News Today: The IIT JAM 2022 exam was held on February 13, 2022, through Computer Based Test (CBT) mode.
India.com Education Desk | Feb 11, 2022, 7:35 PM IST
IIT JAM 2022 Latest News Today: The IIT Roorkee has also issued a letter along with the admit card for the candidates which will act as travel passes to facilitate smooth movement.
India.com Lifestyle Staff | Jan 18, 2022, 10:50 AM IST
Prof Nath said that a wound is defined as a breach in the skin or body tissues due to injury.
India.com News Desk | Nov 3, 2021, 4:11 PM IST
The Hyderabad-based company further said that the approval is based on the availability of additional stability data, which was submitted to Central Drugs Standard Control(CDSCO).
India.com News Desk | Aug 24, 2021, 7:15 PM IST
The Department of Biotechnology further said that the Vaccine Subject Expert Committee (SEC) reviewed the interim Phase 1 data and found that the HGCO19 vaccine was safe, tolerable, and immunogenic in the participants of the study.
India.com News Desk | Aug 13, 2021, 6:54 PM IST
As per the updates, Phase 1 clinical trial has been completed in age groups ranging 18 to 60 years.
PTI Feeds | Feb 19, 2019, 5:06 PM IST
Many brands selling sub-standard liquor in Punjab: FDA
English
